Trials / Conditions / Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
4 registered clinical trials studyying Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Hypofractionation Radiotherapy in Combination with Glofitamab in Relapsed/refractory Diffuse B-cell Lymphoma w NCT06867536 | Liling Zhang | Phase 2 |
| Completed | A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma NCT03992339 | Antengene Corporation | Phase 2 |
| Completed | Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relaps NCT03391466 | Kite, A Gilead Company | Phase 3 |
| Terminated | Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cel NCT03287817 | Autolus Limited | Phase 1 / Phase 2 |